Millennium Management LLC Sells 66,226 Shares of STERIS plc (NYSE:STE)

Millennium Management LLC lessened its holdings in shares of STERIS plc (NYSE:STE - Free Report) by 58.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 46,521 shares of the medical equipment provider's stock after selling 66,226 shares during the quarter. Millennium Management LLC's holdings in STERIS were worth $9,563,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of STE. Magnolia Capital Advisors LLC raised its holdings in shares of STERIS by 1.9% in the 4th quarter. Magnolia Capital Advisors LLC now owns 2,534 shares of the medical equipment provider's stock worth $521,000 after acquiring an additional 48 shares during the last quarter. Park Edge Advisors LLC increased its stake in STERIS by 1.1% in the 4th quarter. Park Edge Advisors LLC now owns 4,662 shares of the medical equipment provider's stock valued at $958,000 after buying an additional 51 shares during the last quarter. Citizens Financial Group Inc. RI increased its stake in STERIS by 5.9% in the 4th quarter. Citizens Financial Group Inc. RI now owns 975 shares of the medical equipment provider's stock valued at $201,000 after buying an additional 54 shares during the last quarter. Opal Wealth Advisors LLC increased its stake in STERIS by 5.7% in the 4th quarter. Opal Wealth Advisors LLC now owns 1,118 shares of the medical equipment provider's stock valued at $230,000 after buying an additional 60 shares during the last quarter. Finally, Sage Private Wealth Group LLC increased its stake in STERIS by 4.1% in the 4th quarter. Sage Private Wealth Group LLC now owns 1,537 shares of the medical equipment provider's stock valued at $316,000 after buying an additional 61 shares during the last quarter. Institutional investors own 94.69% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have commented on STE shares. Stephens reiterated an "overweight" rating and issued a $250.00 price objective on shares of STERIS in a research note on Thursday, May 15th. JMP Securities increased their price target on shares of STERIS from $265.00 to $280.00 and gave the company a "market outperform" rating in a research report on Friday, May 16th. Needham & Company LLC restated a "hold" rating on shares of STERIS in a research report on Monday, April 7th. Wall Street Zen upgraded shares of STERIS from a "buy" rating to a "strong-buy" rating in a research report on Thursday, May 22nd. Finally, Piper Sandler increased their price target on shares of STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. Two investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $264.00.

STERIS Price Performance

Shares of STERIS stock traded down $0.33 on Wednesday, reaching $245.87. The stock had a trading volume of 278,517 shares, compared to its average volume of 594,479. STERIS plc has a 1 year low of $200.98 and a 1 year high of $252.79. The company has a market cap of $24.16 billion, a P/E ratio of 52.24 and a beta of 0.96. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The business's 50 day moving average is $227.02 and its two-hundred day moving average is $220.44.

STERIS (NYSE:STE - Get Free Report) last released its quarterly earnings results on Wednesday, May 14th. The medical equipment provider reported $2.74 EPS for the quarter, beating analysts' consensus estimates of $2.59 by $0.15. The firm had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.47 billion. STERIS had a net margin of 8.66% and a return on equity of 13.91%. The business's revenue for the quarter was up 5.7% on a year-over-year basis. During the same period in the previous year, the business earned $2.58 EPS. As a group, research analysts anticipate that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 26th. Stockholders of record on Tuesday, June 10th will be given a dividend of $0.57 per share. The ex-dividend date of this dividend is Tuesday, June 10th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 0.93%. STERIS's dividend payout ratio (DPR) is currently 36.77%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.